Heart & Blood Pressure
Ranexa Assistance Programs & Grants in Utah
Assistance information last verified: August 2026
Not from the manufacturer, and the reason is unusual: Gilead has moved out of cardiovascular medicine. Its access programs name no Ranexa or ranolazine route at all, and ranexa.com no longer serves a site. What a Medicare beneficiary has instead is generic ranolazine from 31 different labelers, which is almost certainly the whole answer. Financial assistance may be available through charitable foundations, manufacturer programs, Medicare's Extra Help program, or other assistance resources. Availability and eligibility change frequently — the information on this page was verified in August 2026.
Can I get help paying for Ranexa?
Not from the manufacturer, and the reason is unusual: Gilead has moved out of cardiovascular medicine. Its access programs name no Ranexa or ranolazine route at all, and ranexa.com no longer serves a site. What a Medicare beneficiary has instead is generic ranolazine from 31 different labelers, which is almost certainly the whole answer.
- Generic ranolazine: 35 labelled products across 31 distinct labelers — the widest generic availability of any medication in this expansion. No application, no waiting, no income test.
- Gilead Medication Access: names NO Ranexa or ranolazine program. Gilead's listed therapeutic areas are Virology, Oncology and Inflammation; cardiovascular medicine is not among them.
- Gilead Advancing Access (1-800-226-2056): presents HIV treatment and prevention only.
- ranexa.com did not complete an HTTPS connection on August 26, 2026 — there is no active brand patient site where a savings card could be published.
- Charitable grants: TotalAssist's CAD health equity fund lists "Ranexa (Ranolazine)" and was closed ($1,000 guaranteed / $1,500 maximum), and it additionally requires a qualifying home zip code. There is no angina fund anywhere, and HealthWell and Good Days have nothing applicable.
- Not a Medicare-negotiated drug for 2026, 2027 or 2028 — unsurprising for a medicine this thoroughly generic.
1 of the 5 programs we checked for Ranexa was accepting applications when verified in August 2026.
About Ranexa (ranolazine)
Ranexa is a twice-daily extended-release tablet taken to reduce episodes of chronic angina — the chest pain that comes from reduced blood flow to the heart. It is unusual in two ways worth knowing: its own label says the mechanism behind its antianginal effect "has not been determined", and it does not lower heart rate or blood pressure the way most heart medicines do. It is also, by some distance, the most comprehensively genericised medication covered on this site.
Approved uses
- Treatment of chronic angina, used alone or alongside beta-blockers, nitrates, calcium channel blockers, antiplatelet therapy, lipid-lowering therapy, ACE inhibitors and angiotensin receptor blockers
Manufacturer: Gilead Sciences
Why Ranexa can be expensive on Medicare
For most people on Medicare, brand Ranexa is not the medication they are actually dispensed, and that is the heart of this page. Ranolazine is available from 31 different labelers — 35 labelled products on DailyMed — so generic ranolazine typically sits on a low generic tier while brand Ranexa sits on a brand tier. If you are paying a brand-tier price for Ranexa, the question to ask is not which program can help but why you are on the brand at all.
Medicare coverage context
Ranexa is a tablet you take yourself, so Medicare covers it under Part D or a Medicare Advantage drug plan — with brand Ranexa on a brand tier and generic ranolazine typically on a much lower generic tier. It is not a Medicare-negotiated drug: CMS's selected-drug and Maximum Fair Price file has no Ranexa or ranolazine row for 2026, 2027 or 2028, which is exactly what you would expect for a medicine with this much generic competition, since the negotiation program selects drugs that do not have it. Part D out-of-pocket costs are capped at $2,100 in 2026, Extra Help lowers cost-sharing for people with limited income and resources, and the Medicare Prescription Payment Plan can spread what you owe across the year. Realistically, though, none of those will be the thing that solves a Ranexa cost problem — the generic will.
Check typical Part D coverage · Estimate your drug costs · Compare Part D plans in Vernal
Ranexa assistance options at a glance
Every program we checked, what kind of help it is, whether people with Medicare can use it, and its status when we verified it. A medication being listed by a program is not the same as the program accepting applications.
About the income limits below: Income limits can differ between assistance programs even when both describe their eligibility as the same percentage of the federal poverty level. The dollar limits shown here come from each program's own published income table, and each program decides which year's poverty guidelines that table is built from and when it takes effect. Treat the figures as belonging to the program they are listed under — they are not interchangeable, and only the program can tell you which table it is applying to your application today.
| Program | Type of help | People with Medicare | Status (August 2026) |
|---|---|---|---|
| Generic ranolazine | Manufacturer self-pay pricing | may apply | Accepting applications |
| Gilead patient assistance — Ranexa not covered | Manufacturer patient assistance | not stated | No program found |
| TotalAssist — Coronary artery disease (CAD) health equity fund | Charitable grant | may apply | Closed to new applicants |
| HealthWell Foundation — no applicable fund | Charitable grant | may apply | No program found |
| Good Days — no applicable fund | Charitable grant | not stated | No program found |
| Medicare Extra Help (Part D Low-Income Subsidy) | Government program | may apply | Accepting applications |
Manufacturer programs from Gilead Sciences
A patient assistance program (free or low-cost drug by income) is not the same as a copay card (a commercial discount that usually excludes Medicare). Both are listed so you can see which one applies to you.
Manufacturer self-pay pricing
Generic ranolazine
Multiple manufacturers
Status: Comprehensively available on August 26, 2026: DailyMed lists 35 labelled ranolazine products across 31 distinct labelers, including Ajanta, Sun Pharmaceutical, American Health Packaging and Vangard Labs.
The answer for essentially everyone reading this page. Thirty-one labelers make generic ranolazine, there is nothing to apply for, and the price gap against a brand tier is large. Ask your prescriber and your plan about it before considering anything else here.
If you have Medicare: A generic is not an assistance program and has no Medicare rule to satisfy — it is the same medicine at a generic tier, available to anyone with a prescription. With 31 labelers competing, generic ranolazine is among the least expensive medications on this site, and switching to it will almost always save more than any program or grant discussed here. TotalAssist also lists ranolazine generically on the same fund as the brand, so a switch costs nothing in fund eligibility.
What it can cover: The same medicine at a generic tier.
Who may qualify
- A prescription written for or substitutable to generic ranolazine extended-release
- No income test, no application and no waiting
How to apply
Ask your prescriber to write for generic ranolazine extended-release, or ask your pharmacy whether it can substitute where state law allows. Ask your plan which labeler's product sits on its preferred tier — with 31 on the market, plans differ.
Manufacturer patient assistance
Gilead patient assistance — Ranexa not covered
Gilead Sciences
Status: Gilead's Medication Access pages named no Ranexa or ranolazine program on August 26, 2026. The therapeutic areas Gilead lists are Virology, Oncology and Inflammation — cardiovascular medicine is not among them. Gilead Advancing Access, the company's access program, presents HIV treatment and HIV prevention only. Separately, ranexa.com did not complete an HTTPS connection, so there is no brand patient site either.
An honest negative with a clear explanation behind it. Gilead is now a virology, oncology and inflammation company; Ranexa is a legacy cardiovascular brand whose molecule went generic long ago. Do not spend time looking for a Gilead program — ask about generic ranolazine instead.
If you have Medicare: Not applicable — Gilead publishes no program covering Ranexa, so none states a Medicare rule for it. This is a different kind of absence from the ones elsewhere in this batch: it is not that a source could not be read, but that the manufacturer has moved on from the therapeutic area entirely, and the brand has been superseded by generics in the meantime.
How to apply
Not applicable for Ranexa. If Gilead adds a cardiovascular program it would appear on the Medication Access pages cited here. Gilead Advancing Access can be reached on 1-800-226-2056 if you want the company to confirm directly.
Charitable grants for Ranexa
The charitable picture for Ranexa is the narrowest of any medication in this expansion, and it barely matters. TotalAssist's 146-fund list contains no angina fund at all; the only fund whose approved-medication list includes "Ranexa (Ranolazine)" is the Coronary artery disease health equity fund, which was closed on August 26, 2026, pays $1,000 guaranteed up to $1,500, and additionally requires a home zip code in a designated social-vulnerability county. HealthWell runs no angina or coronary artery disease fund, and neither does Good Days. But with 31 labelers making generic ranolazine, the cost problem this medication presents is one that a prescriber can usually solve in a sentence. Set the TotalAssist alert if the zip-code requirement fits you, and otherwise put your effort into the generic.
Charitable grant
TotalAssist — Coronary artery disease (CAD) health equity fund
Patient Advocate Foundation · Coronary artery disease (CAD) health equity
Status: Closed to new applicants on August 26, 2026, with a $1,000 guaranteed and $1,500 maximum award. This fund additionally requires a home zip code in a designated social-vulnerability county, so it is narrower than most funds on this site even when open.
"Ranexa (Ranolazine)" is named on the CAD health equity approved-medication list, alongside Brilinta, Plavix, Effient, the statins, beta-blockers and nitrates. Two limits worth knowing: it was closed, and it is a health-equity fund with a geographic requirement. There is no angina fund anywhere in TotalAssist's 146-fund list, so this is the only route.
If you have Medicare: This fund requires government-insured coverage — Medicare, Medicaid or TRICARE — that covers your qualifying expenses. Medicare beneficiaries are eligible when it is open and when the zip-code requirement is met.
What it can cover: When open: $1,000 guaranteed award and up to $1,500 maximum for medication copays, coinsurance, deductibles and health-insurance premiums. One grant per condition.
Who may qualify
- Confirmed coronary artery disease diagnosis, in treatment, starting within 60 days, or treated in the past 6 months
- Government-insured coverage (Medicare, Medicaid or TRICARE) that covers your qualifying expenses
- Household income at or below 500% of the federal poverty level, adjusted for your regional cost-of-living index
- Confirmed diagnosis matching the fund, and in treatment (or starting within 60 days, or treated in the past 6 months)
- Legal U.S. resident receiving treatment in the U.S. or a U.S. territory
- A home zip code in a designated social-vulnerability county — a requirement specific to health-equity funds
What the application asks for
- Contact information and Social Security number (or alien number)
- Annual household income (for pre-screening; proof of income due within 30 days of approval)
- Health insurance carrier, plan type, policy ID and group number; Medicare supplement or secondary insurance if you have one
- Copay or coinsurance amounts
- Your provider's name and contact information, diagnosis (exact date if within 6 months), prescribed medications and treatment plan
How to apply
Sign up for fund notifications (text, email or automated call) at totalassist.org/notify. When a fund opens: You (the patient) apply online — it takes about 15 minutes and you learn immediately whether you are approved — or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis and treatment plan directly with your provider and verifies income automatically; you have 30 days after approval to provide proof of income.
Charitable grant
HealthWell Foundation — no applicable fund
HealthWell Foundation
Status: HealthWell's published disease-fund list on August 26, 2026 contained no angina, coronary artery disease or ischemic heart disease fund. Its nearest cardiovascular funds — Chronic Heart Failure – Medicare Access and Cardiomyopathy – Medicare Access — are different diagnoses and were both closed.
An honest negative. HealthWell opens new funds as well as reopening old ones, so the disease-funds list is worth an occasional look — but there is nothing for angina today.
If you have Medicare: HealthWell accepts Medicare beneficiaries for the diseases it covers. It covers no diagnosis that would apply to Ranexa, so no Medicare rule is engaged.
How to apply
Not applicable today. The disease-funds page lists every fund HealthWell runs and its status.
Charitable grant
Good Days — no applicable fund
Good Days
Status: Good Days' published disease list on August 26, 2026 contained 57 programs and none was angina or coronary artery disease.
An honest negative, checked so you do not spend time on a third foundation that has no fund for you.
If you have Medicare: Good Days accepts Medicare beneficiaries for the diseases it covers, but it covers no diagnosis that applies to Ranexa.
How to apply
Not applicable today. The diseases-covered page shows every fund Good Days runs.
How to apply for Ranexa assistance
The written steps are complete on their own; the video above will walk through the same process when it is published.
-
Step 1 — Find the applicable assistance program
For Ranexa on Medicare in August 2026 the list is short, because the manufacturer route does not exist and the generic usually settles it:
- Ask your prescriber and plan about generic ranolazine extended-release — 35 labelled products from 31 labelers. This is the step that solves the problem for almost everyone.
- Limited income and resources → Medicare Extra Help through Social Security, mainly for your other medications.
- Coronary artery disease diagnosis AND a qualifying home zip code → set an alert on the TotalAssist CAD health equity fund (closed when checked).
- Cost still unmanageable → ask about a formulary exception, and compare Part D plans in the fall.
- Do not spend time on Gilead — it publishes no cardiovascular assistance program.
-
Step 2 — Check whether applications are currently open
There is no manufacturer application to check for Ranexa. What can change is fund status.
- Gilead: the Medication Access pages are where a cardiovascular program would appear if the company introduced one.
- TotalAssist: the CAD health equity fund page shows "Open" or "Closed" and the current award amounts.
- HealthWell: worth re-checking the disease-funds list occasionally, since HealthWell opens new funds as well as reopening old ones.
-
Step 3 — Check eligibility
Only three things here have eligibility rules, and the most useful has none:
- Generic ranolazine: no eligibility rules — a prescribing and formulary question, which is what makes it the first thing to ask about.
- TotalAssist CAD health equity (when open): government insurance covering Ranexa or ranolazine; income at or below 500% FPL adjusted for your regional cost-of-living index; a confirmed coronary artery disease diagnosis; AND a home zip code in a designated social-vulnerability county.
- Extra Help: income below about $23,940 a year for one person or $32,460 for a couple, and countable resources limited to $18,090 or $36,100 in 2026.
- Gilead: not applicable, because it publishes no program covering Ranexa.
-
Step 4 — Gather your information
Whichever route you take, these are what will be asked for:
- Medicare card and your Part D or Medicare Advantage drug-plan card, with policy ID and group number.
- Your chronic angina or coronary artery disease diagnosis and its date. TotalAssist needs the exact date if it was within the past 6 months.
- Your Ranexa strength — 500 mg or 1000 mg extended-release — and that it is taken twice daily.
- A list of your other heart medications, since the label expressly contemplates Ranexa being used alongside beta-blockers, nitrates, calcium channel blockers and others.
- Household size and annual household income, plus proof.
-
Step 5 — Complete the application
Who fills out what:
- Generic switch: nothing to apply for — your prescriber writes it, or the pharmacy substitutes where state law allows.
- Extra Help: you (or someone helping you) apply free through Social Security — online, by phone on 1-800-772-1213, or at an office. There is never a fee.
- TotalAssist (when open): you apply online in about 15 minutes or by phone on 866-512-3861.
- Formulary exception: your prescriber's office submits it to your plan.
-
Step 6 — Submit and wait for a determination
What to expect:
- Extra Help: Social Security notifies you by mail; your Part D plan then applies the lower copays.
- TotalAssist (when open): an immediate online decision, with proof of income due within 30 days of approval.
- Formulary exception: plans generally must respond within a set timeframe; your prescriber's office can tell you what to expect.
-
Step 7 — If the program is closed or you don't qualify
With no manufacturer program in the picture, this step is where the money is:
- Ask specifically about generic ranolazine extended-release. It is the same medicine at a generic tier, it is on the same TotalAssist fund list as the brand, and with 31 labelers it is among the cheapest medications on this site.
- If your pharmacy is dispensing brand Ranexa, ask why. With this much generic competition, being on the brand is usually a prescribing or formulary artefact rather than a clinical necessity — though your prescriber is the one to confirm that.
- Ask your prescriber's office about a formulary exception if your plan will not cover the generic.
- Apply for Extra Help even if you assume you earn too much; the limits are higher than most people expect.
- Never stop taking an antianginal to save money — talk to your prescriber first, because uncontrolled angina is a clinical problem, not a budgeting one.
- Call Vernal Medicare — we will work through every route above with you, free.
What you'll need
Only items the programs above actually ask for. Gather these before you start.
- Medicare card and your Part D or Medicare Advantage drug-plan card — plan name, member ID and group number
- Prescription details — medication name, strength and dose; prescriber name, office phone and address
- Diagnosis and date of diagnosis — TotalAssist needs the exact date if diagnosed within the past 6 months
- Household size and annual household income — and proof — tax return, Social Security or pension statements, or pay stubs
- Your Ranexa strength — 500 mg or 1000 mg extended-release — taken twice daily
- Your home zip code — the only TotalAssist fund covering Ranexa is a health-equity fund requiring a designated social-vulnerability county
- A list of your other heart medications — the label contemplates Ranexa being used alongside beta-blockers, nitrates and others
Could Medicare Extra Help reduce your Ranexa costs?
Extra Help is not a grant for Ranexa. It is a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription — so it is worth checking even when a charitable fund is closed, because it does not depend on fund balances.
Extra Help is worth applying for on its own merits — it lowers cost-sharing on every covered drug you take, and with full Extra Help a covered brand-name drug costs about $12.65 in 2026, with generics lower still. But be realistic about Ranexa specifically: generic ranolazine is inexpensive enough that Extra Help's effect on this particular prescription will be modest. Apply because of everything else in your medicine cabinet, not because of this one.
In 2026, people with full Extra Help generally pay no more than $12.65 for a covered brand-name drug. Income must be below about $23,940 a year for one person ($32,460 for a couple) and countable resources under $18,090 ($36,100 for a couple). Apply free through Social Security — online, by phone at 1-800-772-1213, or in person — and never pay anyone to apply for you.
Extra Help explained (Utah) · Check if you might qualify · Medicare Savings Programs · All help paying for Medicare
Government program
Medicare Extra Help (Part D Low-Income Subsidy)
Medicare / Social Security Administration
Status: Year-round federal program (figures for 2026)
Not a grant for one drug — a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription.
If you have Medicare: For people with Medicare Part D or a Medicare Advantage drug plan who have limited income and resources.
What it can cover: Part D premium and deductible (often to $0) and reduced copays — generally no more than $12.65 for a covered brand-name drug in 2026 with full Extra Help.
Who may qualify
- Income below 150% of the federal poverty level — about $23,940 a year for one person or $32,460 for a married couple in 2026.
- Countable resources (savings, investments — not your home or car) limited to $18,090 for an individual or $36,100 for a married couple living together in 2026 (Medicare.gov figures, which include a burial-expense allowance).
- Automatic if you have Medicaid, Supplemental Security Income (SSI), or a Medicare Savings Program.
What the application asks for
- Social Security number and Medicare number
- Income (Social Security, pensions, wages) for you and a spouse you live with
- Value of savings, investments and other countable resources
How to apply
You (or someone helping you) apply free through Social Security — online, by phone, or at a Social Security office. There is never a fee to apply.
Key terms on this page
- Patient assistance program (PAP)
- A manufacturer program that provides its medication free or at low cost to people who meet income and insurance rules. Many PAPs accept Medicare Part D enrollees; each sets its own criteria.
- Copay card / savings card
- A manufacturer discount for commercially insured patients. Federal anti-kickback rules mean these cards generally cannot be used with Medicare, Medicaid or other government insurance.
- Charitable copay grant
- Money from a nonprofit foundation (for example HealthWell or Patient Advocate Foundation) that pays eligible copays or coinsurance for a specific diagnosis. A drug can be listed while the fund is closed to new applicants.
- Federal poverty level (FPL)
- A federal income measure that assistance programs use as a yardstick — "300% of FPL", "500% of FPL". The percentage is a rule, but the dollar figure behind it comes from a table each program publishes itself, built on a chosen year of the HHS poverty guidelines. Two programs can quote the same percentage in the same year and still list different dollar limits; compare each program against its own table, not against another program.
- Medicare Extra Help
- The Part D Low-Income Subsidy: a Medicare program that lowers or eliminates Part D premiums, deductibles and copays for beneficiaries with limited income and resources. You apply through Social Security.
- Maximum Fair Price (MFP)
- The price Medicare negotiated for a selected drug under the Medicare Drug Price Negotiation Program. It applies to Part D plans, not to the pharmacy cash price, and it lowers what plans and enrollees pay for that drug.
Related medication assistance guides
Frequently Asked Questions
Does Medicare cover Ranexa?
Is there a Ranexa patient assistance program for people on Medicare?
Is there a generic for Ranexa?
How does Ranexa work, and is it a blood thinner?
Is there a charitable grant for Ranexa right now?
Is Ranexa part of Medicare drug price negotiation?
Sources
- Ranexa prescribing information (DailyMed) — U.S. National Library of Medicine (2026-08-26)
- DailyMed label index — ranolazine — U.S. National Library of Medicine (2026-08-26)
- Gilead Sciences Medication Access Programs — Gilead Sciences (2026-08-26)
- Gilead Advancing Access — Gilead Sciences (2026-08-26)
- ranexa.com — brand patient site — Gilead Sciences (2026-08-26)
- TotalAssist — Coronary artery disease (CAD) health equity fund — Patient Advocate Foundation (2026-08-26)
- TotalAssist fund list and status — Patient Advocate Foundation (2026-08-26)
- Get notified when a fund opens — TotalAssist — Patient Advocate Foundation (2026-08-26)
- TotalAssist eligibility requirements — Patient Advocate Foundation (2026-08-26)
- HealthWell disease funds (full list) — HealthWell Foundation (2026-08-26)
- HealthWell disease funds (status list) — HealthWell Foundation (2026-08-26)
- Good Days — diseases covered — Good Days (2026-08-26)
- Selected Drug List and Negotiated Prices (Maximum Fair Prices) data file — CMS (2026-08-26)
- Your Medicare in 2026: what you need to know — Medicare.gov (2026-08-26)
- Help with drug costs (Extra Help) — Medicare.gov (2026-08-26)
- Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons — HHS Office of Inspector General (2026-08-26)
Having trouble figuring out your prescription costs?
If you live in Vernal or the Uintah Basin, Vernal Medicare can help you understand your Medicare prescription coverage and where to look for Ranexa assistance — free, no pressure. We don't award grants or decide eligibility; the programs above do. We help you find and apply to the right ones.